Regeneron Pharmaceuticals REGN
NASDAQ REGN
$790.74 -5.60 (-0.70%)
At close: Oct 16, 2026 · 4:00 PM EDT

Regeneron Pharmaceuticals (REGN) Non Operating Interest Expenses (2009 - 2026)

Updated

Regeneron Pharmaceuticals' Non Operating Interest Expenses was $11 million in Q2 2026, up 205.6% from $3.6 million a year earlier but down 14.7% from the prior quarter.

Analysis

Regeneron Pharmaceuticals (REGN) Non Operating Interest Expenses (2009 - 2026) Analysis & Trends

On a trailing twelve-month basis, Regeneron Pharmaceuticals' Non Operating Interest Expenses was $55.4 million through Jun 30, 2026, up 51.4% year-over-year; for FY2025, it came in at $43.8 million, down 20.7% from FY2024.

  • Non Operating Interest Expenses shows a five-year compound annual growth rate of -5.1% (FY2020 to FY2025).
  • In earlier years, Non Operating Interest Expenses was $55.2 million in FY2024 (-24.4%), $73 million in FY2023 (+22.9%), $59.4 million in FY2022 (+3.7%) and $57.3 million in FY2021 (+0.7%).
  • Quarterly Non Operating Interest Expenses has moved between $3.6 million (Q2 2025) and $19.3 million (Q3 2025) over five years.
  • Compared with a year earlier, Non Operating Interest Expenses has increased for four straight quarters, with growth averaging 15.4% over the last eight quarters.
  • The best year-over-year quarter for Non Operating Interest Expenses over five years was Q2 2026 (growth of 205.6%); the worst was Q2 2025 (a decline of 75.7%).
  • Per Business Quant data, REGN's Non Operating Interest Expenses in the three quarters before Q2 2026 was $12.9 million (Q1 2026), $12.2 million (Q4 2025) and $19.3 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn -
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn 281.00 Mn
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn -
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn -
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn 462.00 Mn
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn 435.00 Mn
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn 673.00 Mn
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn 247.00 Mn
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn -
10 Regeneron Pharmaceuticals 81.27 Bn 47.47 Bn 3.71 Bn 11.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 11.00 Mn
Mar 31, 2026 12.90 Mn
Dec 31, 2025 12.20 Mn
Sep 30, 2025 19.30 Mn
Jun 30, 2025 3.60 Mn
Mar 31, 2025 8.70 Mn
Dec 31, 2024 10.50 Mn
Sep 30, 2024 13.80 Mn
Jun 30, 2024 14.80 Mn
Mar 31, 2024 16.10 Mn
Dec 31, 2023 18.30 Mn
Sep 30, 2023 17.80 Mn
Jun 30, 2023 18.90 Mn
Mar 31, 2023 18.00 Mn
Dec 31, 2022 17.40 Mn
Sep 30, 2022 15.30 Mn
Jun 30, 2022 13.10 Mn
Mar 31, 2022 13.60 Mn
Dec 31, 2021 14.10 Mn
Sep 30, 2021 14.20 Mn
API Access

Regeneron Pharmaceuticals Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=REGN&period=max&api_key=YOUR_API_KEY